Indo Us Bio-Tech Ltd - 541304 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- CS Dimpy JoshiDesignation :- Company Secretary and Compliance Officer Indo Us Bio-Tech Ltd - 541304 - Addendum To The Notice Dated July 9, 2022 Convening AGM
In reference to the captioned subject, it had come to knowledge of Management, post sending the notice, that addition / alteration of certain details and information in the original Notice would make it more convenient for stakeholders and members to take an informed decision and to apprise the facts and nitty gritty of the agenda proposed in the ensuing meeting. Thus, the management of the Company have concluded to issue an addendum to the erstwhile notice for information and perusal by the members. The said addendum is being sent to the members via e-mail. A copy of said addendum is enclosed herewith for your records and information please. Request you to kindly disseminate the same on website of Exchange for prompt information of our stakeholders. Indo Us Bio-Tech Ltd - 541304 - Reg. 34 (1) Annual Report.
Dear Sir, Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annual Report of the Company for the financial year ended 2021-2022 including Notice convening the 18th Annual General Meeting of the Company, to be held on Monday, 1st August, 2022 at 11:30 am. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). Kindly take the above information on your record. Thanking You, Yours faithfully, Indo Us Bio-Tech Ltd - 541304 - Newspaper Advertisement For The Notice Of 18Th Annual General Meeting Of The Company.
Dear Sir, Please find enclosed herewith a copy of each newspaper clipping of the advertisement published in Financial Express (English) and Financial Express (Gujarati) on Saturday, 09.07.2022, in terms of Ministry of Corporate Affairs Circular No. 20/2020 dated 5th May, 2020, inter-alia, intimating that the 18th Annual General Meeting of the Company will be held on Monday, 1st August, 2022 at 11:30 a.m. through VC / OAVM facility. Kindly take the above information on your record. Thanking You, Yours faithfully, Indo Us Bio-Tech Ltd - 541304 - Intimation Of Book Closure For The Purpose Of 18Th AGM Pursuant To Regulation 42 Of SEBI (LODR)
Dear Sir/Madam, The 18th Annual General Meeting (AGM) of the Company is scheduled on Monday,1st August, 2022 through Video Conferencing or other Audio-Visual means in accordance with the General Circulars issued by the Ministry of Corporate Affairs dated April 8, 2020 and April 13, 2020 and SEBI Circular dated May 12, 2020, in view of the prevailing COVID-19 pandemic. In terms of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, this is to inform you that the Register of Members and Share Transfer Book of the Company shall remain closed from Monday, 25th July, 2022 to Sunday, 31st July, 2022 (both days inclusive) in terms of Section 91 of the Companies Act 2013 for taking records of the members of the Company for the purpose of 18th Annual General Meeting, scheduled to be held on Monday, 1st August, 2022. You are requested to take the same on your record. Thanking You. Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting- AGM On August 01, 2022
Dear Sir, With reference to the above captioned subject and in terms of applicable regulations of SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015 we hereby submit a copy of the Notice of 18th Annual General Meeting of the Company schedule to be held on Monday, 1st August, 2022 at 11.30 A.M. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). Kindly take the above information on your record. Thanking You, Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, 8Th July, 2022
In reference with above subject, and advance intimation in the matter, the Board met today, discussed and resolved the agendas mentioned in the attached document. The Meeting commenced at 16.30 Hrs and concluded at 17:30 Hrs. Do acknowledge the receipt of same. Disseminate the above announcement on BSE's Website. Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Postponement Of Board Meeting
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/07/2022 ,inter alia, to consider and approve In reference with above subject, we had intimated on June 24, 2022 about meeting of Board being scheduled today, i.e Saturday, July 2, 2022 at the registered office of the Company. Due to unavoidable reasons, the said meeting have been postponed to Friday, July 8, 2022, with same agendas for consideration. Indo Us Bio-Tech Ltd - 541304 - Board Meeting Intimation for Intimation Of Board Meeting
Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2022 ,inter alia, to consider and approve In reference with above subject, the meeting of Board is scheduled on Saturday, July 2, 2022 at the registered office of the Company to inter alia transact the following business: 1. To consider and approve Date, Time, Venue, Notice of AGM. 2. To consider options for equity expansion, fresh fund raising via various available instruments and to simultaneously consider increasing the Authorized capital of the company. 3. To transact any other business with the permission of chairman. Indo Us Bio-Tech Ltd - 541304 - Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015
It may please note that as per Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the compliance with the Corporate Governance Provisions as specified in regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para-C, D and E of Schedule V shall not apply, in respect of having paid up equity share capital not exceeding rupees Ten Crores and Net worth not exceeding rupees Twenty-Five Crore, as on the last day of the Previous financial year, The Listed Entity which has listed its specified securities on the SME Exchange. Since our Company does not have paid up equity and Net Worth of minimum level as per above referred regulation and it is listed under BSE SME Platform Therefore, our Company is not required to submit Related Party Transactions disclosure as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015.